Trial to study findings in skin changes due to leprosy, remaining after completion of treatment in leprosy patients
Not Applicable
- Conditions
- Health Condition 1: - Health Condition 2: A305- Lepromatous leprosy
- Registration Number
- CTRI/2020/11/028927
- Lead Sponsor
- none
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients of either gender with age >18 years.
2.Leprosy patients with persistent skin lesions ,those who didnâ??t show desired response in
terms of no change in skin lesions or still showing signs of disease activity in terms of
infiltrated lesions or occurrence of new lesions, after completing 6 months of paucibacillary and 12 months of multibacillary MDT.
3.Patients who can give valid consent.
Exclusion Criteria
1.Patients with lepra reaction.
2.Those who are not willing to provide consent for the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To observe the clinical,Slit skin smear findings, Histopathological findings in treated cases of <br/ ><br>leprosy with persistent skin lesions after completion of 6 months of paucibacillary and 12 months of multibacillary WHO Multidrug therapy.Timepoint: Baseline
- Secondary Outcome Measures
Name Time Method To assess the frequency of drug resistance in these patientsTimepoint: Baseline